Use GleanMark for a free trademark search powered by millions of USPTO records. See similar trademarks, filter results, and sign up for active monitoring.
Dietary supplements; nutritional supplements; dietary supplements and nutritional supplements containing butyric acid; pharmaceutical preparation, namely butyric acid being a dietary ingredient manufactured by a proprietary process that results in butyric acid being absorbed in the intestinal tract in a time-dependent manner; pharmaceutical feature in the nature of a sustained-release delivery ingredient in the nature of dietary supplements and nutritional supplements, made in whole or significant part from butyric acid, sold as an integral component of dietary supplements and nutritional supplements for increasing the level of butyric acid in the gastrointestinal tract to maintain an optimal inflammatory response in the gastrointestinal tract.
(Based on 44(e)) Pharmaceutical and veterinary preparations for treatment of digestive system disorders; Dietary substances for medical purposes, namely, dietetic food adapted for medical use; Dietary substances for medical purposes, namely, dietary and nutritional supplements adapted for medical use; Baby food
Dietary supplements; nutritional supplements; medical foods, namely, medical food supplements and dietetic food supplements, both containing short-chain fatty acids in single molecule form with a release agent that enhances solubility and absorption; nutritional ingredients, namely, a blend of nutrients, namely, short-chain fatty acids in single molecule form with a release agent that ensures solubility and absorption, that are an integral component of medicals foods, for short-chain fatty acid deficiencies in individuals with Autism Spectrum Disorder; nutraceuticals for use as dietary supplements and nutritional supplements; vitamin preparations and mineral preparations to mitigate short-chain fatty acid microbiome deficiencies in individuals with Autism Spectrum Disorder; dietary supplements for restoring health in individuals with diseases, disorders, nutritional deficiencies, and adverse health conditions; therapeutic agents for human medical, medicinal, and therapeutic purposes, namely, increasing butyric acid in the gastrointestinal tract; functional nutrients containing butyric acid and acetic acid to mitigate short- chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; pharmaceutical preparations to mitigate short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder; specialty nutraceuticals for the dietary management of diseases, disorders, and nutritional deficiencies, namely, short-chain fatty acid gut microbiome deficiencies in individuals with Autism Spectrum Disorder and deficiencies of butyrate in the gastrointestinal tract
